A citation-based method for searching scientific literature

S Goya Wannamethee, Peter H Whincup, Lucy Lennon, Olia Papacosta, Gordon D Lowe. J Am Geriatr Soc 2014
Times Cited: 24







List of co-cited articles
23 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.
A G Shaper, S J Pocock, M Walker, N M Cohen, C J Wale, A G Thomson. Br Med J (Clin Res Ed) 1981
483
16


Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study.
Jeffrey K Lee, Ricki Bettencourt, David Brenner, Thuy-Anh Le, Elizabeth Barrett-Connor, Rohit Loomba. PLoS One 2012
46
12

Inflammatory markers in population studies of aging.
Tushar Singh, Anne B Newman. Ageing Res Rev 2011
460
12

Physical activity and hemostatic and inflammatory variables in elderly men.
S Goya Wannamethee, Gordon D O Lowe, Peter H Whincup, Ann Rumley, Mary Walker, Lucy Lennon. Circulation 2002
330
8

Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study.
Augusto Di Castelnuovo, Amalia de Curtis, Simona Costanzo, Mariarosaria Persichillo, Marco Olivieri, Francesco Zito, Maria Benedetta Donati, Giovanni de Gaetano, Licia Iacoviello. Haematologica 2013
49
8

Inflammatory markers and incident mobility limitation in the elderly.
Brenda W J H Penninx, Stephen B Kritchevsky, Anne B Newman, Barbara J Nicklas, Eleanor M Simonsick, Susan Rubin, Michael Nevitt, Marjolein Visser, Tamara Harris, Marco Pahor. J Am Geriatr Soc 2004
215
8

Chronic inflammation is associated with low physical function in older adults across multiple comorbidities.
Tina E Brinkley, Xiaoyan Leng, Michael E Miller, Dalane W Kitzman, Marco Pahor, Michael J Berry, Anthony P Marsh, Stephen B Kritchevsky, Barbara J Nicklas. J Gerontol A Biol Sci Med Sci 2009
193
8

Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels.
Luigi Ferrucci, Brenda W J H Penninx, Stefano Volpato, Tamara B Harris, Karen Bandeen-Roche, Jennifer Balfour, Suzanne G Leveille, Linda P Fried, Jack M Guralnik Md. J Am Geriatr Soc 2002
390
8


Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men.
S Goya Wannamethee, Peter H Whincup, Lucy Lennon, Ann Rumley, Gordon D Lowe. Stroke 2012
40
8


Inflammation and frailty in the elderly: A systematic review and meta-analysis.
Pinar Soysal, Brendon Stubbs, Paola Lucato, Claudio Luchini, Marco Solmi, Roberto Peluso, Giuseppe Sergi, Ahmet Turan Isik, Enzo Manzato, Stefania Maggi,[...]. Ageing Res Rev 2016
328
8

Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria.
Bernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, Casper G Schalkwijk, Coen Stehouwer, Hans-Henrik Parving, Peter Karl Jacobsen, Peter Rossing. J Diabetes Complications 2016
35
8

Total and cause-specific mortality in the cardiovascular health study.
Anne B Newman, Michael C Sachs, Alice M Arnold, Linda P Fried, Richard Kronmal, Mary Cushman, Bruce M Psaty, Tamara B Harris, John A Robbins, Gregory L Burke,[...]. J Gerontol A Biol Sci Med Sci 2009
61
8

Interleukin-6 in aging and chronic disease: a magnificent pathway.
Marcello Maggio, Jack M Guralnik, Dan L Longo, Luigi Ferrucci. J Gerontol A Biol Sci Med Sci 2006
364
8

Proinflammatory cytokines, aging, and age-related diseases.
Martin Michaud, Laurent Balardy, Guillaume Moulis, Clement Gaudin, Caroline Peyrot, Bruno Vellas, Matteo Cesari, Fati Nourhashemi. J Am Med Dir Assoc 2013
482
8

Interleukin-6 as a first-rated serum inflammatory marker to predict mortality and hospitalization in the oldest old: A regression and CART approach in the BELFRAIL study.
Wim Adriaensen, Catharina Matheï, Bert Vaes, Gijs van Pottelbergh, Pierre Wallemacq, Jean-Marie Degryse. Exp Gerontol 2015
23
8

Blood-borne biomarkers of mortality risk: systematic review of cohort studies.
Evelyn Barron, Jose Lara, Martin White, John C Mathers. PLoS One 2015
49
8

Standardisation of spirometry.
M R Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, R Crapo, P Enright, C P M van der Grinten, P Gustafsson,[...]. Eur Respir J 2005
8

Cohort Profile Update: The British Regional Heart Study 1978-2014: 35 years follow-up of cardiovascular disease and ageing.
Lucy T Lennon, Sheena E Ramsay, Olia Papacosta, A Gerald Shaper, S Goya Wannamethee, Peter H Whincup. Int J Epidemiol 2015
40
8

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, Jie Xiang, Yeming Wang, Bin Song, Xiaoying Gu,[...]. Lancet 2020
8

A novel coronavirus outbreak of global health concern.
Chen Wang, Peter W Horby, Frederick G Hayden, George F Gao. Lancet 2020
8

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.
Norihiro Nishimoto, Kazuyuki Yoshizaki, Nobuyuki Miyasaka, Kazuhiko Yamamoto, Shinichi Kawai, Tsutomu Takeuchi, Jun Hashimoto, Junichi Azuma, Tadamitsu Kishimoto. Arthritis Rheum 2004
573
4



Measurement of patient outcome in arthritis.
J F Fries, P Spitz, R G Kraines, H R Holman. Arthritis Rheum 1980
4

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
P E Lipsky, D M van der Heijde, E W St Clair, D E Furst, F C Breedveld, J R Kalden, J S Smolen, M Weisman, P Emery, M Feldmann,[...]. N Engl J Med 2000
4

IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice.
W Kozak, M J Kluger, D Soszynski, C A Conn, K Rudolph, L R Leon, H Zheng. Ann N Y Acad Sci 1998
134
4

Fibrinogen and fibrin structure and functions.
M W Mosesson. J Thromb Haemost 2005
912
4

Very early improvements in the wrist and hand assessed by power Doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis.
Kensuke Kume, Kanzo Amano, Susumu Yamada, Kazuhiko Hatta, Noriko Kuwaba, Hiroyuki Ohta. Arthritis Care Res (Hoboken) 2011
11
9

Anti-cytokine therapy for rheumatoid arthritis.
R N Maini, P C Taylor. Annu Rev Med 2000
288
4

Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.
Helena Forsblad-d'Elia, Karin Bengtsson, Lars Erik Kristensen, Lennart T H Jacobsson. Rheumatology (Oxford) 2015
32
4


High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.
Claire Immediato Daïen, Sarah Gailhac, Rachel Audo, Thibault Mura, Michael Hahne, Bernard Combe, Jacques Morel. Rheumatology (Oxford) 2015
27
4

Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review.
Israa Al-Shakarchi, Nicola J Gullick, David L Scott. Patient Prefer Adherence 2013
20
5

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.
Josef S Smolen, Andre Beaulieu, Andrea Rubbert-Roth, Cesar Ramos-Remus, Josef Rovensky, Emma Alecock, Thasia Woodworth, Rieke Alten. Lancet 2008
986
4


Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
Mark C Genovese, Joan M Bathon, Richard W Martin, Roy M Fleischmann, John R Tesser, Michael H Schiff, Edward C Keystone, Mary Chester Wasko, Larry W Moreland, Arthur L Weaver,[...]. Arthritis Rheum 2002
584
4


Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Josef S Smolen, Jonathan Kay, Mittie K Doyle, Robert Landewé, Eric L Matteson, Jürgen Wollenhaupt, Norman Gaylis, Frederick T Murphy, Jeffrey S Neal, Yiying Zhou,[...]. Lancet 2009
382
4

Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.
R N Maini, P C Taylor, J Szechinski, K Pavelka, J Bröll, G Balint, P Emery, F Raemen, J Petersen, J Smolen,[...]. Arthritis Rheum 2006
572
4



Rheumatoid arthritis.
D M Lee, M E Weinblatt. Lancet 2001
898
4

Concordant message of different inflammatory markers in patients with rheumatoid arthritis.
N G Arvidsson, B Gudbjörnsson, R Hällgren, A Larsson. Ups J Med Sci 1998
12
8

Humanized antihuman IL-6 receptor antibody, tocilizumab.
N Nishimoto, T Kishimoto. Handb Exp Pharmacol 2008
94
4


Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis.
Christian Enevold, Bo Baslund, Louise Linde, Norah L Josephsen, Ulrik Tarp, Hanne Lindegaard, Søren Jacobsen, Claus H Nielsen. Pharmacogenet Genomics 2014
26
4

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.
F C Arnett, S M Edworthy, D A Bloch, D J McShane, J F Fries, N S Cooper, L A Healey, S R Kaplan, M H Liang, H S Luthra. Arthritis Rheum 1988
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.